SELLAS Life Sciences (SLS) Inventory Average (2013 - 2015)
SELLAS Life Sciences (SLS) posted quarterly Inventory Average of $1.0 million for Q2 2015, up 160.81% year-over-year from $395500.0 in Q2 2014, and up 59.67% quarter-over-quarter from $646000.0 in Q1 2015.
SELLAS Life Sciences (SLS) Inventory Average (2013 - 2015) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Inventory Average for 3 consecutive years, with $1.0 million the latest figure, recorded in Q2 2015.
- In Q2 2015, Inventory Average rose 160.81% year-over-year to $1.0 million; the TTM figure through Jun 2015 stood at $1.0 million (up 160.81% YoY), while the FY2014 annual figure was $520500.0, changed N/A from the prior year.
- Inventory Average grew to $1.0 million in Q2 2015 per SLS's latest filing, from $646000.0 in the prior quarter.
- Across five years, Inventory Average topped out at $1.0 million in Q2 2015 and bottomed at $372000.0 in Q1 2014.
- Historically, Inventory Average has averaged $529125.0 across 3 years, with a median of $423500.0 in 2013.
- Annual changes were most pronounced in 2014 — Inventory Average increased 13.64% — and 2015, when it surged 160.81%.
- SELLAS Life Sciences' Inventory Average stood at $405500.0 in 2013, then soared by 36.25% to $552500.0 in 2014, then jumped by 86.7% to $1.0 million in 2015.
- Business Quant data shows SLS's Inventory Average at $1.0 million in Q2 2015, $646000.0 in Q1 2015, and $552500.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.03 Mn |
| Mar 31, 2015 | 646,000.00 |
| Dec 31, 2014 | 552,500.00 |
| Sep 30, 2014 | 441,500.00 |
| Jun 30, 2014 | 395,500.00 |
| Mar 31, 2014 | 372,000.00 |
| Dec 31, 2013 | 405,500.00 |
| Sep 30, 2013 | 388,500.00 |